HBV patients with the immune-tolerant phenotype showed a high susceptibility to develop HCC compared to immune active HBV patients, confirming the hypothesis that the presence of HBV-specific CD8+T-cells that are functionally unable to remove the virus induced continuous inflammation followed by tumor development [156]. The gene discussed is CD8A; the disease is neoplasm.